CitiusTech launches Healthcare’s First end-to-end Generative AI Quality & Trust Solution

0
62
CitiusTech launches Healthcare’s First end-to-end Generative AI Quality & Trust Solution
CitiusTech launches Healthcare’s First end-to-end Generative AI Quality & Trust Solution

CitiusTech’s Gen AI Quality & Trust Solutions fully integrate into existing MLOps, DataOps, and Quality Management Solutions and anchor to healthcare use cases and outcomes.

February 15, 2024, Princeton, N.J.: CitiusTech, a leading provider of healthcare technology services and solutions, announced that it has launched an industry-first solution for healthcare organizations to help address the reliability, quality, and trust requirements for generative AI (Gen AI) solutions. The CitiusTech Gen AI Quality & Trust solution will help organizations design, develop, integrate, and monitor quality and facilitate trust in Gen AI applications, providing the confidence needed to adopt and scale Gen AI applications enterprise-wide.

“We are working with many clients on Gen AI solutions. But we find that over 80% of Gen AI proofs of concept and initiatives are delayed due to reliability and compliance concerns, due to a lack of trust in Gen AI solutions. This is the pain point we are trying to solve for our customers and the healthcare industry at large,” said Rajan Kohli, CEO, CitiusTech. “By prioritizing trust, quality, and reliability, we empower our clients to fully embrace Gen AI technologies, gaining potential competitive advantages in the healthcare sector. We are integrating this capability seamlessly into all our solutions and projects, ensuring our clients can confidently benefit from scaling Gen AI-powered solutions.”

Our solution offering is a software-based framework coupled with consulting, implementation, and support services. It leverages a state-of-the-art automated design and decision-making framework that will provide pre-packaged measures, automated output validation, and monitoring of the quality and trustworthiness of Gen AI solutions.

“At present, there are no established technology or platform-agnostic solutions that measure the quality and trust of healthcare Gen AI solutions, end-to-end. Approaches used in building and evaluating LLMs and foundation models are useful but have not been designed for healthcare,” said Sridhar Turaga, SVP – Data and Analytics, CitiusTech. “Our Gen AI Quality and Trust Solution is the first systematic approach in healthcare to quantitatively measure, verify, and monitor Gen AI solutions. This solution also synthesizes and builds on work by AI researchers, platform players, industry forums, and regulatory bodies. We go beyond pure math or technology and contextualize everything in the healthcare context.”

CitiusTech’s Gen AI Quality & Trust Solutions fully integrate into existing MLOps, DataOps, and Quality Management Solutions and anchor to healthcare use cases and outcomes. Organizations can leverage our healthcare-specific repository of 70+ metrics and 25+ methods across 7 dimensions: accuracy, calibration, robustness, fairness, bias, toxicity, and efficiency. Multiple clients and healthcare innovators have beta-tested this approach, which has helped shape this offering.

Also readAs a technology leader, I cultivated the knack of understanding one step above the others so that I can handle them, says Dr. Chandran Raghuraman, CTO at Bahwan Cybertek

Do FollowCIO News LinkedIn Account | CIO News Facebook | CIO News Youtube | CIO News Twitter 

About us:

CIO News, a proprietary of Mercadeo, produces award-winning content and resources for IT leaders across any industry through print articles and recorded video interviews on topics in the technology sector such as Digital Transformation, Artificial Intelligence (AI), Machine Learning (ML), Cloud, Robotics, Cyber-security, Data, Analytics, SOC, SASE, among other technology topics.